- PatentNew
- Trademark
- Innovation
- Solutions
- Contact
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- Best-in-class Customer ExperienceOur goal is to exceed our clients' expectations and share best practices
- IP TrainingIncrease the IP-IQ of your entire organization with engaging IP training programs
- Resource Hub
- Newsletter subscriptionSign up for our quarterly patent and trademark newsletters and set your email preferences below.
- Newsletter subscription
- About Questel
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- Best-in-class Customer ExperienceOur goal is to exceed our clients' expectations and share best practices
- IP TrainingIncrease the IP-IQ of your entire organization with engaging IP training programs
- Resource Hub
- Newsletter subscriptionSign up for our quarterly patent and trademark newsletters and set your email preferences below.
- Newsletter subscription
- About Questel
Why Multiple Embodiments Are So Helpful in Patent Cases
Imagine this: Company A owns a patent for an energy efficient lawnmower. Company B starts manufacturing a lawnmower that looks eerily similar. When Company A finds out, it sends a cease & desist letter. Company B fights back, saying its product is not infringing. They go to court, where a deciding authority — a judge, examiner or board — delves into Company A’s patent claims to determine what legally constitutes infringing activity.
The language in the claims is at the very core of this decision: If it is strong and clear, then the semantic investigation will probably work out in favor of Company A, the patent owner. If the patent claims are vague, Company B could win the case.
How to protect yourself
To avoid being on the losing end of such a judgement, IP applicants should consider listing multiple embodiments on their patent applications. The Oxford Dictionary defines an embodiment as “the representation or expression of something in a tangible or visible form.” On a patent application, an embodiment is a detailed description of how an invention can be made or used. It’s not enough to assume that this is obvious or implied – it must be explicitly stated to take advantage of maximum protection.
For example, if there are multiple methods of making an invention or if it is an invention that has (or could have) multiple uses, the patent applicant should list every possible embodiment they can imagine in the specification. Doing so makes it less likely that an infringer will later be able to exploit vagueness in the issued patent.
Global patent filing
Remember Companies A and B above? Now that you understand how critical patent semantics can be, one of the most important steps you can take when filing for protection in multiple countries is to ensure that you have translated every embodiment accurately. You want there to be as little interpretive “wiggle room” as possible should IP litigation occur.
IP litigation can be particularly challenging when a determination is to be made by a judge, examiner or board that is familiar with a different IP system, language and culture from your own. An LSP that specializes in international patent filing can make sure that every application you file is translated accurately and appropriately.
Case study: Purdue vs Alvogen
In the case Purdue Pharma L.P. vs Alvogen Pine Brook LLC, one point of contention clearly illustrates the importance of thoroughly listing multiple embodiments. Here’s what happened:
- Purdue Pharma owned U.S. Patent No. 9,750,703 for “encased tamper resistant controlled release dosage forms.”
- Purdue Pharma used this technology to create Butrans, a prescription medication used to “treat pain that continues around-the-clock.” Butrans comes in the form of a patch that contains an extended-release opioid absorbed through the skin over a period of 7 days.
- While Butrans was still patent-protected, Alvogen, another life science company, started marketing a generic version of the extended-release pain medication.
- Purdue Pharma claimed Alvogen’s generic version infringed upon Patent No. 9,750,703.
- The case went to the Delaware District Court, where Purdue won.
A closer look at Patent No. 9,750,703
In discussing a time-release shell for a pharmaceutical, the following phrase in Patent No. 9,750,703 became critical to Purdue’s win: “A layer encasing the core and comprising a second portion of hydrocodone bitartrate dispersed in a second matrix material.” At issue was the meaning of “layer encasing the core.” Did the patent refer to, and protect only, a single-material layer, as Alvogen asserted? If so, it couldn’t apply to a shell made up of multiple materials, as their product did.
Ultimately, the court to come to a conclusion after reviewing the following embodiment regarding different ways Purdue’s shell could be constructed: “The shell of the dosage form can be formed, e.g., by compression coating, molding, spraying one or more layers onto the core, dipping one or more layers onto the core or a combination thereof.” As such, the court sided with Purdue and concluded that the term ‘layer encasing the core’ means “one or more materials enclosing a space or surrounding the core.”
The takeaway here is that because Purdue’s application was farsighted enough to include these multiple embodiments — i.e. the various ways in which their shell could be created — they were able to prevail in the infringement suit against Alvogen.
How multiple embodiments are especially invaluable with global patents
If you plan to protect your patents in multiple countries, the last place you want to find yourself is in a legal dispute in front of a foreign authority who has to read between your lines. Working with an LSP that can anticipate potential local unclarities can, ultimately, make a huge difference. By knowing each region’s IP system, being absolutely fluent in the local language, and understanding the cultural lens through which the details in your filing may one day be viewed, the right LSP can help ensure your IP protection is rock-solid and uncontestable.